Technology
Health
Medical

Ra Medical

$3.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (0.78%) Today
+$0.03 (0.78%) Today

Why Robinhood?

You can buy or sell Ra Medical and other stocks, options, ETFs, and crypto commission-free!

About

Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. Read More It operates through the Dermatology and Vascular business segments. The company was founded by Dean Irwin and Melissa Burstein in 2002 and is headquartered in Carlsbad, CA.

Employees
118
Headquarters
Carlsbad, California
Founded
2002
Market Cap
49.11M
Price-Earnings Ratio
Dividend Yield
Average Volume
112.44K
High Today
$4.00
Low Today
$3.81
Open Price
$3.99
Volume
39.11K
52 Week High
$22.00
52 Week Low
$3.76

Collections

Technology
Health
Medical
2018 IPO
US
North America

News

Seeking AlphaMar 15

Ra Medical down 28% on soft Q1 guidance

Thinly traded nano cap Ra Medical Systems (RMED -27.7% ) is down on modestly higher volume following its Q4 report released after the close yesterday.

9
Seeking AlphaMar 15

Ra Medical Systems, Inc. (RMED) CEO Dean Irwin on Q4 2018 Results - Earnings Call Transcript

Ra Medical Systems, Inc. (NYSE:RMED) Q4 2018 Earnings Conference Call March 14, 2019 4:30 PM ET Company Participants Kevin McCabe - LHA Investor Relations Dean Irwin - Chief Executive Officer, Chief Technology Officer and Chairman of the Board of Directors Thomas Fogarty - Chief Commercial Officer Andrew Jackson - Chief Financial Officer Conference Call Participants Andrew Stafford - Piper Jaffray Bruce Nudell - SunTrust Robinson Humphrey, Inc. Anthony Vendetti - Maxim Group, LLC Operator Ladies ...

26
BusinessWireMar 14

Ra Medical Systems Reports 2018 Fourth Quarter and Full Year Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today reported financial results for the three and 12 months ended December 31, 2018 and provided a business update. Recent Operational Highlights Signed 19 new DABRA usage agreements during the fourth quarter of 2018, increasing the total number of agreements to 53 as of December 31, 2018, with varying volumes o...

1

Earnings

-$1.18
-$0.90
-$0.63
-$0.35
Q3 2018
Q4 2018
Estimated
-$0.38 per share
Actual
-$1.18 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.